| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |